Literature DB >> 28602844

Primate-specific Long Non-coding RNAs and MicroRNAs.

Hassaan Mehboob Awan1, Abdullah Shah1, Farooq Rashid1, Ge Shan2.   

Abstract

Non-coding RNAs (ncRNAs) are critical regulators of gene expression in essentially all life forms. Long ncRNAs (lncRNAs) and microRNAs (miRNAs) are two important RNA classes possessing regulatory functions. Up to date, many primate-specific ncRNAs have been identified and investigated. Their expression specificity to primate lineage suggests primate-specific roles. It is thus critical to elucidate the biological significance of primate or even human-specific ncRNAs, and to develop potential ncRNA-based therapeutics. Here, we have summarized the studies regarding regulatory roles of some key primate-specific lncRNAs and miRNAs.
Copyright © 2017. Production and hosting by Elsevier B.V.

Entities:  

Keywords:  Evolution; LncRNA; MicroRNA; Non-coding RNA; Primate-specific

Mesh:

Substances:

Year:  2017        PMID: 28602844      PMCID: PMC5487532          DOI: 10.1016/j.gpb.2017.04.002

Source DB:  PubMed          Journal:  Genomics Proteomics Bioinformatics        ISSN: 1672-0229            Impact factor:   7.691


Introduction

RNA is believed to be the precursor to all the current life forms on earth. The RNA World, first posited in late 1960s, proposes that self-replicating RNA molecules initially contained both the information and the function needed for their perpetuation before the emergence of the first cell [1]. Over the course of time, information contained in RNA had been passed on to the more stable DNA, while most catalytic functions were delegated to more versatile proteins, thereby limiting the role of RNA as an intermediate between genes and proteins [2]. The human genome contains approximately twenty thousand protein-coding genes [3], which make up to 2% of the entire genomic sequence, whereas more than 80% of the genome is pervasively transcribed [4]. Pervasive transcription of human genome is in stark contrast to the small portion of transcription of protein-coding genes. Given their abundance, most of these so-called non-coding RNAs (ncRNAs), which are not translated into proteins, were previously believed to be spurious transcriptional noises arising due to low fidelity of the RNA polymerase (RNAP) [5]. However, accumulating findings have demonstrated that a lot of these ncRNAs play vital roles in many life events [6], [7], [8], [9], [10]. ncRNAs can generally be classified into either housekeeping or regulatory ncRNAs. The housekeeping ncRNAs are constitutively expressed, which include tRNAs, rRNAs, small nuclear RNAs (snRNAs), and small nucleolar RNAs (snoRNAs). Regulatory ncRNAs, on the other hand, can further be classified into long ncRNAs (lncRNAs) and small ncRNAs based on the transcript length. The former has transcript length of greater than 200 bp, whereas the latter has transcript length of less than 200 bp [11]. lncRNAs can be placed into six categories on the basis of their proximity to the protein-coding genes in the genome. An lncRNA is categorized as sense or antisense if the sequence of the lncRNA overlaps the sense or antisense strand of a protein-coding gene, respectively. If the sequence of the lncRNA is present on the opposite strand of a nearby protein-coding gene and transcription of both are initiated in close genic proximity, then the lncRNA transcripts are called divergent lncRNAs. Intronic lncRNAs are derived entirely from within the intron of another transcript. They can be classified as sense-overlapping or antisense if the lncRNA gene lies within the intron of coding gene on the same strand or on the opposite strand, respectively [11]. These lncRNAs can either be a product of pre-mRNA processing or the result of an independent transcription [11], [12]. Intergenic lncRNAs (lincRNAs), on the other hand, are located in the genomic interval between two protein-coding genes [12]. Small ncRNAs are very diverse and include microRNAs (miRNAs), P-element-induced wimpy testis-interacting RNAs (piRNAs), and small interfering RNAs (siRNAs) [13], [14], [15], [16]. miRNAs are the most studied small ncRNAs, representing approximately 4% of the genes in human genome and regulating more than one third of the expressed genes post transcriptionally [17]. Roughly half of the miRNA genes are present in the intergenic regions under control of their own promoters or shared promoters in case of poly-cistronic microRNA clusters [18]. The remaining miRNA genes are located within protein-coding gene, where they are under the influence of host-gene promoters or miRNA-specific promoters [18], [19]. RNAPII-transcribed miRNA transcript undergo subsequent processing in nucleus and cytoplasm to give rise to the mature miRNA [19], [20], which gets incorporated into the RNA-induced silencing complex (RISC). By means of partially or fully complementary base-pairing between 5′ seed sequences of miRNAs and target mRNAs, miRNAs repress protein translation and/or induce mRNA decay [21]. The conservation of seed region is important in grouping miRNAs into families [22], [23], [24]. Undoubtedly, RNAs are constantly evolving, starting from the RNA world. New ncRNAs have also been emerging in primates after their separation from other mammals [25]. lncRNAs and miRNAs are the most analyzed ncRNAs from the evolutionary view, and a handful of primate-specific lncRNAs and miRNAs have been studied for their lineage-specific roles.

Evolution of lncRNAs

As it has been observed that majority of the lncRNAs exhibit low sequence conservation, they may exhibit different pattern of conservation in contrast to protein-coding genes. While protein-coding genes must preserve the ORF in order to retain the function, lncRNAs on the other hand maintain their functionality by means of preserving their short sequence stretches or structural motifs that may serve as functional domains [26]. The conservation of lncRNAs can be at the sequence, genomic synteny, functional, or structural level. There are various mechanisms by which lncRNAs may have originated. The first such mechanism is the gradual transformation of a protein-coding gene sequence into functional ncRNA sequence [12]. For instance, Xist encodes an lncRNA critical for the X-chromosome inactivation in eutherian mammals. Although well conserved in eutherians, Xist homolog is not found in other mammals [27]. Except the six exons containing tandem repeats, the promoter region and the remaining four out of ten exons of Xist gene have sequence homology with Lnx3 that encodes the ligand of numb protein-X 3, a ubiquitin E3 ligase [28]. Evolution of Xist lncRNA was therefore thought to result partially from the loss of function of the protein-coding gene. This event occurred after the divergence between eutherians and marsupials, suggesting independent evolution of dosage compensation in both lineages [27]. Another possibility of lncRNA origin is chromosome rearrangement. Two untranscribed sequences that were previously well-separated juxtaposed each other, giving rise to an lncRNA. An example for this kind of lncRNA origin comes from the observation that a dog testis-derived lncRNA (supported by ESTs BM537447, C0597044, and DN744681) emerged in canid lineage approximately 80 million years ago after the last common ancestor of canids and bovids [12]. It is of note that this lncRNA locus spans two regions that are tens of megabases apart in other eutherian mammals [12], [29]. Except for a few extensively-studied lncRNAs, origin of most lncRNAs still remains vague. Duplication of lncRNA to give rise to a new lncRNA has also been proposed. For instance, mouse nuclear enriched abundant transcript 2 (Neat2) [30] and mouse testis-derived lncRNA AK019616 are paralogous to each other [28]. However, two independent studies in zebrafish and humans have shown that lncRNAs rarely have extensive sequence similarity outside of the shared repetitive elements [31], [32]. These observations suggest that lncRNA genes, instead of originating from duplication events, arise de novo from non-exonic sequence or from transposable elements (TEs) [33]. Another possible way by which a functional lncRNA could emerge is by the TE insertion. Owing to their ability to move and spread in the genome, as well as their potential to introduce regulatory sequences, TEs represent a major force in increasing the lncRNA repertoire [33]. Besides duplication events or insertion of TEs, new lncRNA genes can also originate through reuse of the general transcriptional context of other functional genes [34]. In one study, it is proposed that new lncRNA genes may originate by strengthening of the U1-polyadenylation signal (PAS) axis that can extend the transcriptional length of lncRNA genes present anti-sense to functional coding genes [35]. Presumably non-coding transcripts, either originating from pervasive transcription or through aforementioned mechanisms, have evolved functional benefits to the specific lineage. They would become functional lineage-specific lncRNAs such as primate-specific ones, which we are going to discuss below.

5S-OT

Alu elements are short stretch of DNA highly abundant in the primate genome. There are more than one million copies of Alu elements dispersed throughout the human genome [36]. Belonging to short interspersed nuclear element (SINE) family, these primate-specific retro-transposable elements (REs) play a major role in shaping the evolution of the genome, thereby constantly regulating the repertoire of the regulatory elements. 5S rRNA is an ancient, highlyconserved ncRNA that is present in essentially all domains of life. Recently, we have described an lncRNA expressed from 5S rDNA locus and therefore named it 5S-OT (OT stands for overlapping transcript) [33]. From fission yeast to humans, this lncRNA is relatively conserved, and regulates the transcription of 5S rRNA by RNAPIII in cis (Figure1A) [37], [38]. Conserved at the sequence, synteny, and functional level in eukaryotic cells, 5S-OT may be one of the most ancient lncRNAs transcribed by RNAPII. In the anthropoidea suborder of primates including humans, however, insertion of an Alu element in the 5S rDNA locus leads to the generation of the 5S-OT lncRNA harboring antisense Alu sequences at the 3′ end. The insertion also creates a polypyrimidine tract (Py) in the sequence of 5S-OT lncRNA, which serves as the site for 5S-OT to interact with splicing factor U2 snRNA auxiliary factor 2 of 65 kDa (U2AF65). 5S-OT then brings U2AF65 to regulate alternative splicing of hundreds of human genes via Alu-mediated antisense:sense RNA−RNA pairing. This unique trans role in pre-mRNA splicing is primate-specific, as 5S-OT of other mammals does not have Py site and thus does not interact with U2AF65. It has been shown in the study that 5S-OT plays critical role in the differentiation of human cells. Since Alu elements are primate-specific, it is highly possible that this Alu and 5S-OT dependent splicing regulation may have contributed to transcriptome divergence of primate from the rest of the mammals [37].
Figure 1

Functional mechanisms of some primate-specific lncRNAs

A. In mammals, 5S-OT regulates its own transcription by acting in cis, whereas in humans it can also act in trans by interacting with splicing factor U2AF65, thus modulating alternate splicing. B. In neural progenitors, lncND is highly expressed sequestering miR-143-3p, thereby indirectly increasing Notch protein expression necessary for maintenance of neural progenitors. During differentiation, expression of lncND decreases and free miR-143-3p represses Notch mRNA, indirectly decreasing Notch protein expression in support of the differentiation of progenitor cells. RNAP, RNA polymerase; U2AF65, U2 snRNA auxiliary factor 2 of 65 kDa.

Functional mechanisms of some primate-specific lncRNAs A. In mammals, 5S-OT regulates its own transcription by acting in cis, whereas in humans it can also act in trans by interacting with splicing factor U2AF65, thus modulating alternate splicing. B. In neural progenitors, lncND is highly expressed sequestering miR-143-3p, thereby indirectly increasing Notch protein expression necessary for maintenance of neural progenitors. During differentiation, expression of lncND decreases and free miR-143-3p represses Notch mRNA, indirectly decreasing Notch protein expression in support of the differentiation of progenitor cells. RNAP, RNA polymerase; U2AF65, U2 snRNA auxiliary factor 2 of 65 kDa.

lncND

Rani et al. have provided evidence for the involvement of a primate-specific lncRNA lncND (ND stands for neuronal development) in regulating an ancient signaling pathway controlling brain development [39]. Phylogenetic analysis shows that lncND is more conserved in Catarrhini (old world monkeys and apes) as compared to Platyrrhini (new world monkeys) [39]. A primate-specific sequence insertion occurred in the 5′ region of lncND. Further scrutinization of the sequence insert reveals the presence of 16 miRNA-recognition elements (MREs) for miR-143-3p. This suggests that lncND has sponging activity, thereby indirectly regulating the protein expression of miR-143-3p target genes. Among the neuro-developmental genes, Notch-1 and Notch-2 each contain a miR-143-3p MRE in the 3′UTR. High expression of lncND in neural progenitor cells as compared to neurons leads Rani and the colleagues to propose that lncND regulates the neuronal differentiation pathway by sequestering the miR-143-3p in early neurogenesis (Figure1B) [39].

lincHPAT5

lincRNAs can be grouped according to the TEs residing in them, since lincRNA transcription takes place from sites frequently enriched with TEs [40]. Human endogenous retrovirus H (HERV-H) family of lincRNA has been linked to human embryonic stem cell (hESC) pluripotency [41], whereas HERV-V and HERV-K families are involved in the pre-implantation embryo development [42]. However, the role of individual lincRNA in pluripotency and embryogenesis is obscure. To answer this question, Durruthy-Durruthy et al. studied 23 human pluripotency-associated transcripts (HPATs) in hESCs [40]. Of the 23 transcripts examined, three transcripts, HPAT2, HPAT3, and HPAT5, showed elevated expression in the inner cell mass (ICM) with HPAT5 being expressed at highest level. siRNA-mediated knockdown of all three HPATs in single blastomere of 2-cell stage human embryo blocked the blastomere from contributing to ICM of the developing embryo, suggesting essential role of these lincRNAs in embryonic development. CRISPR knockout of endogenous HPAT5 (HPAT5-KO) in hESCs demonstrated that HPAT5 plays key roles in the pluripotency network. Sequence analysis revealed presence of MREs of let-7 family of miRNAs in HPAT5. The let-7 targeting of HPAT5 is due to a point mutation occurring within Alu element of HPAT5, which generated let-7 seed sequence maybe in great apes 5–9 million years ago [40].

FMRR4

There has been increasing interest in finding and characterizing lncRNAs with reference to their relevance to human disease. Fragile X syndrome (FXS) is a genetic disorder. A CGG triplet repeat occurs in the promoter of the gene encoding fragile X mental retardation gene 1 (FMR1) on X-chromosome, leading to the reduced or abolished expression of fragile X mental retardation protein (FMRP). A study in 2008 reported that a primate-specific lncRNA FMR4 is located upstream of FMR1. FMR4 likely shares a bidirectional promoter with FMR1. Knockdown of FMR1 did not have any effect on FMR4 expression, and vice versa. Interestingly, expression of both FMR1 and FMR4 is silenced in FXS patients. siRNA-mediated knockdown of FMR4 followed by FACS analysis suggests the antiapoptotic function of FMR4. It should be noted that FMR4 seems to be conserved in primates [43].

PRINS

Another interesting lncRNA relevant to disease is psoriasis susceptibility-related RNA gene induced by stress (PRINS) that was identified a decade ago [44]. Psoriasis is a human-specific autoimmune skin disease affecting 2%−4% population, which has not yet been identified in other primates [45]. In psoriatic non-lesional epidermis, a 3.6-kb-long non-coding transcript was identified with two exons harboring three Alu elements collectively [44]. PRINS lncRNA is found to be specific to primates as well [45].

Evolution of miRNAs

Evolutionary history of miRNAs is complicated. Although some miRNAs show deep sequence conservation throughout the animal kingdom, frequent gain and loss of miRNAs have also been observed [25], [46], [47]. This is because evolution of new miRNA genes, maybe due to their ability to form non-perfect fold back structures recognizable by miRNA machinery, is more likely to occur as compared to protein-coding genes [48]. There can be different ways by which a novel miRNA gene can arise in the genome. One way is the local or tandem duplication of an existing miRNA gene followed by subfunctionalization and neofunctionalization process [49], [50]. RNA molecules have the inherent property to form secondary structures. Gradual evolution of unstructured transcripts, often arising from introns to form hairpin structures identifiable by miRNA biogenesis machinery, can also give birth to new miRNA genes [48]. It has been observed that evolutionarily younger, species-specific miRNAs are more often located in introns [51]. These new miRNA genes are also enriched with TEs, since TEs can provide novel transcriptional units for the evolution of miRNA-like hairpins into novel miRNA genes [49], [52], [53], [54]. Another way by which novel miRNA genes can originate in the genome is through antisense transcription of an existing miRNA gene, resulting in the production of mature miRNA with a distinct seed sequence [55]. Comparative genomics studies indicate that primate-specific miRNAs contribute considerably to human-specific miRNAs. In one study, phylogenetic analysis of human miRNAs against metazoan genomes reveals that 41% of miRNAs originated in primates, with only 1% to be human-specific [46]. In another study, out of 1433 human miRNAs analyzed, 53% of them originated within great ape lineage, whereas 28% originated in hominoid lineage, and another 28% were associated with radiation of placental mammals. No more than 15% human miRNAs were conserved beyond placental mammals [47]. In a more recent study, 3707 novel miRNAs were found in the human genome, with 57% of them specific to humans [56]. Thus, the number of primate- or even human-specific miRNAs is large. Due to space limitation, we have not mentioned primate-specific miRNAs that are involved in cancer progression [22] or other cellular functions [57], [58].

C19MC cluster

Although miRNA genes are often located within the introns of protein-coding genes, ‘free’ miRNA genes may also exist. While some miRNA genes can be solitary, they can also be organized in the form of clusters, suggesting origin from a common ancestor [18]. One such cluster known as chromosome 19 miRNA cluster (C19MC) is the largest one in human genome [59]. An exceptionally high gene density distinguishes chromosome 19 from other chromosomes [60]. With genomic span of 100 kb, C19MC consists of 46 genes encoding 59 different mature miRNAs [59]. Alu elements, which are spread over whole clusters, are thought to have facilitated the expansion of C19MC [61], [62]. Interestingly, when compared to other genomes, C19MC was exclusively present in primates. Despite its enormous size, the functions of miRNAs originating from this cluster are largely unknown. About 13.4% of the miRNAs expressed at early development are encoded by C19MC cluster [63], [64], [65], whereas their expression is non-significant in adult tissues [66], [67], suggesting a critical role of these miRNAs in embryogenesis. Intriguingly, C19MC is regulated by genomic imprinting. It is expressed exclusively from the paternal allele during early embryogenesis and become silent later on during development [68]. Notably, placenta is the only organ that escapes epigenetic silencing, where paternal allele remains active until birth [69]. Preeclampsia (PE) is a human pregnancy-specific disease, resulting from dysregulation of human trophoblast invasion and differentiation on or after the 20th gestation week. With significant maternal and neonatal morbidity and mortality, PE accounts for approximately 50,000 deaths worldwide annually [70], [71]. Upon differentiation of cytotrophoblast (CytT) to syncytiotrophoblast (SynT), there is a downregulation in expression of miR-515 family members that belong to C19MC. However, expression of miR-515-5p is markedly upregulated in the placenta of PE women [71]. This upregulation is owing to the interaction of the proto-oncogene protein c-MYC with the E-boxes upstream of pri-miR-515-1 and pri-miR-515-2, thereby inhibiting SynT differentiation (Figure2A). miR-515-5p target genes are critical for SynT differentiation. Their expression was decreased upon overexpression of miR-515-5p, thereby impairing SynT differentiation. This suggests that miR-515-5p plays a pivotal role in human trophoblast differentiation [71].
Figure 2

Functional mechanisms of some primate-specific miRNAs

A. miR-515-5p resides in the C19MC. In preeclampsia, proto-oncogene c-MYC interacts with the E-boxes upstream of pri-miR-515. This interaction increases the expression of miR-515 thus inhibiting the differentiation of cytotrophoblasts (CytT) to syncytiotrophoblast (SynT). B. miR-603 resides in the intron of KIAA1217 gene. Hair-pin structure of pre-miR-603 harboring rs11014002 SNP is stable. By directly targeting LRPAP1, miR-603 indirectly increases the expression of LRP1 protein, thus reducing the risk of AD. C19MC, chromosome 19 miRNA cluster; LRP1, low-density lipoprotein receptor-related protein 1; LRPAP1, LRP-associated protein 1; AD, Alzheimer’s disease.

Functional mechanisms of some primate-specific miRNAs A. miR-515-5p resides in the C19MC. In preeclampsia, proto-oncogene c-MYC interacts with the E-boxes upstream of pri-miR-515. This interaction increases the expression of miR-515 thus inhibiting the differentiation of cytotrophoblasts (CytT) to syncytiotrophoblast (SynT). B. miR-603 resides in the intron of KIAA1217 gene. Hair-pin structure of pre-miR-603 harboring rs11014002 SNP is stable. By directly targeting LRPAP1, miR-603 indirectly increases the expression of LRP1 protein, thus reducing the risk of AD. C19MC, chromosome 19 miRNA cluster; LRP1, low-density lipoprotein receptor-related protein 1; LRPAP1, LRP-associated protein 1; AD, Alzheimer’s disease.

X-linked primate-specific miRNA cluster

Another interesting primate-specific miRNA cluster is located at Xq27.3 of primate X-chromosome. The cluster is well conserved within primate genome, but is virtually absent from other mammalian genomes [72]. Absence of this cluster in non-primate genomes suggests that the formation of this cluster took place after primate-rodent split but before emergence of new-world monkeys. The cluster consists of 6 distinct miRNAs, which span a genomic region of approximately 33 kb. Functional analysis of members of this cluster shows that they are predominantly expressed in the human epididymis [72]. On the basis of their location and sequence similarity, members of this miRNA cluster can be phylogenetically divided into two regions, and each region is shaped by different evolutionary events. Among them, miR-890, miR-888, miR-892a, and miR-892b are tightly clustered within a genomic region of 3 kb and are highly similar with each other, suggesting evolution of these members as a result of tandem duplication events. The other two miRNAs (miR-891b and miR-891a), although similar to each other, do not show similarity with the other members of this cluster, suggesting that these two miRNAs may have experienced different evolutionary events to position them onto this locus [67], [72], [73]. In silico studies show that members of this miRNA cluster target genes controlling epididymal physiology, sperm maturity, male fertility, and tube development. Nonetheless, functional role of this miRNA cluster still needs to be further validated [72], [74].

Neuropsychiatric disorder-related miRNAs

Among the neuropsychiatric disorders, major depressive disorder (MDD) is a prevalent mood disorder commonly treated using antidepressants [75], [76]. Metabolic glutamate receptor-4 (GRM4) modulates neurotransmitters, and is localized pre- and post-synaptically. Known for its involvement in regulation of anxiety-related behaviors, GRM4 is considered to be an attractive drug target [77], [78]. The primate-specific miR-1202 has recently been shown to target GRM4 [79]. In silico sequence comparison among 100 animal genomes shows that miR-1202 is present only in primates. miR-1202 is further validated experimentally to have higher expression in humans as compared to non-human primates [79]. Notably, higher GRM4 protein expression is also detected in postmortem brain samples and clinical samples from patients with depression, suggesting negative correlation with the expression of miR-1202 [79]. These studies suggest that miR-1202 could be a potential target for new antidepressant treatment as well as biomarker for treatment prediction and response [79]. Bipolar disorder (BD) is another neuropsychiatric disorder characterized by frequent mood swings between depression and mania. Abnormalities in neuronal synapses are thought to be a contributing factor toward pathogenesis of BD [80]. For instance, a recent study has shown the association between a primate-specific miRNA, miR-1908-5p, and the pathogenesis of BD. Previously uncharacterized, miR-1908-5p is shown to target genes that function in neuronal glutamatergic synapses, which includes DLGAP4, GRIN1, STX1A, CLSTN1, and GRM4. In silico brain expression profiles also show inverse correlation between the expression of miR-1908-5p and its target genes [80].

Alzheimer’s disease-related miRNAs

Alzheimer’s disease (AD) is a neurodegenerative disorder leading to progressive loss of memory, behavioral issues and functional decline in ability to learn. It accounts for more than 80% of the dementia cases globally [81]. Low-density lipoprotein receptor-related protein 1 (LRP1) is an important player in preventing neurodegeneration. LRP1 maintains brain lipid homeostasis in order to maintain neuronal integrity [82]. Patients with AD have reduced protein levels of LRP1 in middle frontal cortexes, whereas LRP1 level in unaffected individuals negatively correlates with the age [82]. Primate-specific miR-603 has recently been shown to have potential role in the pathogenesis of AD. miR-603 is an intronic miRNA expressed from the host gene KIAA1217, and is highly expressed in brain [83]. Interestingly, a single nucleotide polymorphism (SNP), rs11014002, in the pre-miR-603 increase stability of the hairpin structure and the production of mature miRNA. LRP-associated protein 1 (LRPAP1) controls LRP1 protein expression by acting as a molecular chaperone to LRP1 [83]. By directly targeting LRPAP1 mRNA, miR-603 indirectly increases the levels of LRP1 protein (Figure2B). Taken together, these observations suggest a potential protective role of miR-603 against AD [84].

Conclusion and perspective

Human genome is estimated to have approximately 20,000 protein-coding genes, which account for less than 2% of the human genome. Could the number of protein-coding genes be correlated to the organismal complexity? Less complex eukaryotes such as nematode Caenorhabditis elegans contain a similar number of protein-coding genes as humans, and about 70% proteins in C. elegans have homologs in humans [85]. It is increasingly appreciated that organismal complexity is not solely dependent on number of protein-coding genes. Alternative splicing of pre-mRNAs as well as modifications on proteins in order to increase diversity and functionality of the proteome play some part in the complexity of an organism as well. Since the identification of lncRNA H19, which is induced during liver development in mice [86], [87], and miRNA lin-4, which regulates LIN-14 in C. elegans [88], there has been a constant increase in the repertoire of ncRNAs owing to the development in RNA sequencing technologies and bioinformatics. Till now, thousands of lncRNAs and miRNAs have been identified, however, the function of many of them have not been experimentally shown yet. Lines of compelling evidence support that ncRNAs are one of, if not the major, drivers of evolution. It is highly possible to detect lineage-specific miRNAs with deep sequencing technology due to quick turnover rate of miRNAs and target sites [89]. It is, therefore, important to differentiate miRNAs detected through RNA-sequencing from experimentally verified functional lineage-specific miRNAs. In this review, we have compiled the primate-specific lncRNAs and miRNAs that have been verified experimentally (Table 1). Beside lncRNAs and miRNAs, we also need to keep in mind that there are other ncRNAs such as circular RNAs that may have primate- or human-specific members [90], [91]. The lncRNAs and miRNAs we discussed are associated with diverse functions, ranging from alternative splicing to neuro development, and some of them are involved in development or human diseases. Therefore, primate-specific ncRNAs can be important diagnostic or therapeutic targets.
Table 1

List of primate-specific lncRNAs and miRNAs discussed in this review

CategoryNameFunctional roleRefs.
lncRNA5S-OTAlternative splicing[37]
lncNDNeuro development[39]
lincHPATEmbryo development[40]
FMR4Antiapoptotic[43]
PRINSPsoriasis disease[44]



miRNAC19MCPreeclampsia; cancers[68]
X-linked miRNA clusterPossible roles in epididymal physiology; sperm maturity; male fertility; tube development[73], [74]
miR-1202Major depressive disorder[79]
miR-1908-5pBipolar disorder[80]
miR-603Pre-miR-603 with rs11014002 SNP having protective effect toward Alzheimer’s disease[83], [84]



List of primate-specific lncRNAs and miRNAs discussed in this review Despite the great advances, there are some limitations that need to be overcome for future studies. For example, one limitation in functional studies of primate-specific ncRNAs is the lack of model organism for in vivo studies. In cancer research, mouse model is an important tool, including germline manipulation and xenograft of human tumors. Exposure of mice to potential carcinogens such as pharmaceutical products, industrial or agricultural agents is a standard method in evaluating hazards of these agents exposing to human population [92]. However, there are examples of rodent carcinogens that are not carcinogenic in humans such as anticonvulsant drug phenobarbital [93]. This shows that although there is a fundamental similarity of carcinogenesis, yet differences in the cancer biology between species do exist [94], [95]. To understand roles of disease-related primate-specific ncRNAs, availability of animal models is essential. For instance, use of monkeys in research can be one option as miRNA dysregulation has been studied in the Huntington’s disease monkey, a transgenic primate model of a human disease [96]. Evolutionarily young ncRNAs hold immense potential in therapeutics where they can serve as novel biomarkers and/or therapeutic targets, especially in diseases affecting organs that have been restructured during primates and human evolution. Without a doubt, future investigations in primate- and human-specific ncRNAs would deepen our understanding of distinctions between primates and other mammals, and may provide medical benefits to humans.

Competing interests

The authors declare no competing interests.
  93 in total

Review 1.  A review on Alzheimer's disease pathophysiology and its management: an update.

Authors:  Anil Kumar; Arti Singh
Journal:  Pharmacol Rep       Date:  2014-09-22       Impact factor: 3.024

Review 2.  Signals from noncoding RNAs: unconventional roles for conventional pol III transcripts.

Authors:  Shanshan Hu; Jing Wu; Liang Chen; Ge Shan
Journal:  Int J Biochem Cell Biol       Date:  2012-07-20       Impact factor: 5.085

3.  Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties.

Authors:  H A Pincus; T L Tanielian; S C Marcus; M Olfson; D A Zarin; J Thompson; J Magno Zito
Journal:  JAMA       Date:  1998-02-18       Impact factor: 56.272

4.  Mammalian microRNAs derived from genomic repeats.

Authors:  Neil R Smalheiser; Vetle I Torvik
Journal:  Trends Genet       Date:  2005-06       Impact factor: 11.639

5.  Neuronal LRP1 knockout in adult mice leads to impaired brain lipid metabolism and progressive, age-dependent synapse loss and neurodegeneration.

Authors:  Qiang Liu; Justin Trotter; Juan Zhang; Melinda M Peters; Hua Cheng; Jianxin Bao; Xianlin Han; Edwin J Weeber; Guojun Bu
Journal:  J Neurosci       Date:  2010-12-15       Impact factor: 6.167

Review 6.  Species differences in the hepatic effects of inducers of CYP2B and CYP4A subfamily forms: relationship to rodent liver tumour formation.

Authors:  B G Lake
Journal:  Xenobiotica       Date:  2009-08       Impact factor: 1.908

7.  A mammalian microRNA expression atlas based on small RNA library sequencing.

Authors:  Pablo Landgraf; Mirabela Rusu; Robert Sheridan; Alain Sewer; Nicola Iovino; Alexei Aravin; Sébastien Pfeffer; Amanda Rice; Alice O Kamphorst; Markus Landthaler; Carolina Lin; Nicholas D Socci; Leandro Hermida; Valerio Fulci; Sabina Chiaretti; Robin Foà; Julia Schliwka; Uta Fuchs; Astrid Novosel; Roman-Ulrich Müller; Bernhard Schermer; Ute Bissels; Jason Inman; Quang Phan; Minchen Chien; David B Weir; Ruchi Choksi; Gabriella De Vita; Daniela Frezzetti; Hans-Ingo Trompeter; Veit Hornung; Grace Teng; Gunther Hartmann; Miklos Palkovits; Roberto Di Lauro; Peter Wernet; Giuseppe Macino; Charles E Rogler; James W Nagle; Jingyue Ju; F Nina Papavasiliou; Thomas Benzing; Peter Lichter; Wayne Tam; Michael J Brownstein; Andreas Bosio; Arndt Borkhardt; James J Russo; Chris Sander; Mihaela Zavolan; Thomas Tuschl
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

8.  miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment.

Authors:  Juan Pablo Lopez; Raymond Lim; Cristiana Cruceanu; Liam Crapper; Caroline Fasano; Benoit Labonte; Gilles Maussion; Jennie P Yang; Volodymyr Yerko; Erika Vigneault; Salah El Mestikawy; Naguib Mechawar; Paul Pavlidis; Gustavo Turecki
Journal:  Nat Med       Date:  2014-06-08       Impact factor: 53.440

9.  microRNA-128a dysregulation in transgenic Huntington's disease monkeys.

Authors:  Jannet Kocerha; Yan Xu; Melinda S Prucha; Dongming Zhao; Anthony W S Chan
Journal:  Mol Brain       Date:  2014-06-13       Impact factor: 4.041

10.  Evidence for co-evolution between human microRNAs and Alu-repeats.

Authors:  Stefan Lehnert; Peter Van Loo; Pushpike J Thilakarathne; Peter Marynen; Geert Verbeke; Frans C Schuit
Journal:  PLoS One       Date:  2009-02-11       Impact factor: 3.240

View more
  32 in total

1.  Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer.

Authors:  Martin Pichler; Cristian Rodriguez-Aguayo; Su Youn Nam; Mihnea Paul Dragomir; Recep Bayraktar; Simone Anfossi; Erik Knutsen; Cristina Ivan; Enrique Fuentes-Mattei; Sang Kil Lee; Hui Ling; Tina Catela Ivkovic; Guoliang Huang; Li Huang; Yoshinaga Okugawa; Hiroyuki Katayama; Ayumu Taguchi; Emine Bayraktar; Rajat Bhattacharya; Paola Amero; William Ruixian He; Anh M Tran; Petra Vychytilova-Faltejskova; Christiane Klec; Diana L Bonilla; Xinna Zhang; Sanja Kapitanovic; Bozo Loncar; Roberta Gafà; Zhihui Wang; Vittorio Cristini; Samir M Hanash; Menashe Bar-Eli; Giovanni Lanza; Ondrej Slaby; Ajay Goel; Isidore Rigoutsos; Gabriel Lopez-Berestein; George Adrian Calin
Journal:  Gut       Date:  2020-01-27       Impact factor: 23.059

2.  CUL4B promotes the pathology of adjuvant-induced arthritis in rats through the canonical Wnt signaling.

Authors:  Chenggui Miao; Jun Chang; Guoxue Zhang; Hao Yu; Lili Zhou; Guoliang Zhou; Chuanlei Zhao
Journal:  J Mol Med (Berl)       Date:  2018-04-06       Impact factor: 4.599

3.  Knockdown of BACE1-AS by siRNA improves memory and learning behaviors in Alzheimer's disease animal model.

Authors:  Wenting Zhang; Hao Zhao; Qian Wu; Wenan Xu; Minwu Xia
Journal:  Exp Ther Med       Date:  2018-06-27       Impact factor: 2.447

Review 4.  lncRNAs in T lymphocytes: RNA regulation at the heart of the immune response.

Authors:  Leah M Plasek; Saba Valadkhan
Journal:  Am J Physiol Cell Physiol       Date:  2020-12-09       Impact factor: 4.249

Review 5.  Circular RNAs: A novel type of non-coding RNA and their potential implications in antiviral immunity.

Authors:  Man Wang; Fei Yu; Wei Wu; Yuan Zhang; Wenguang Chang; Murugavel Ponnusamy; Kun Wang; Peifeng Li
Journal:  Int J Biol Sci       Date:  2017-11-02       Impact factor: 6.580

6.  Using Human iPSC-Derived Neurons to Uncover Activity-Dependent Non-Coding RNAs.

Authors:  Mainá Bitar; Stefanie Kuiper; Elizabeth O'Brien; Guy Barry
Journal:  Genes (Basel)       Date:  2017-12-20       Impact factor: 4.096

7.  Long non-coding RNA GAS5 suppresses pancreatic cancer metastasis through modulating miR-32-5p/PTEN axis.

Authors:  Zhi-Qiang Gao; Jun-Feng Wang; De-Hua Chen; Xue-Song Ma; Yang Wu; Zhe Tang; Xiao-Wei Dang
Journal:  Cell Biosci       Date:  2017-12-04       Impact factor: 7.133

8.  Induction of miR-3648 Upon ER Stress and Its Regulatory Role in Cell Proliferation.

Authors:  Farooq Rashid; Hassaan Mehboob Awan; Abdullah Shah; Liang Chen; Ge Shan
Journal:  Int J Mol Sci       Date:  2017-06-29       Impact factor: 5.923

9.  Recently Evolved Tumor Suppressor Transcript TP73-AS1 Functions as Sponge of Human-Specific miR-941.

Authors:  Haiyang Hu; Jian-Mei Liu; Zhenyu Hu; Xi Jiang; Xiaode Yang; Jiangxia Li; Yao Zhang; Haijing Yu; Philipp Khaitovich
Journal:  Mol Biol Evol       Date:  2018-05-01       Impact factor: 16.240

Review 10.  Noncoding RNA therapeutics - challenges and potential solutions.

Authors:  Melanie Winkle; Sherien M El-Daly; Muller Fabbri; George A Calin
Journal:  Nat Rev Drug Discov       Date:  2021-06-18       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.